Skip to main content

Market Overview

12 Biggest Mid-Day Gainers For Monday



  • Array Biopharma Inc (NASDAQ: ARRY) shares jumped 57.9 percent to $5.76 after the company disclosed that its COLUMBUS Phase 3 study of encorafenib plus binimetinib for BRAF-mutant melanoma has met primary endpoint.
  • Lipocine Inc (NASDAQ: LPCN) shares climbed 23.4 percent to $4.80 after the company reported positive top-line Phase 2b study results for LPCN 1111.
  • Chemtura Corp (NYSE: CHMT) shares surged 15.8 percent to $32.63 as LANXESS AG NPV (OTC: LNXSF) announced Sunday, it has signed a contract to acquire the company for $33.50 per share in cash or $2.5 billion.
  • Actua Corp (NASDAQ: ACTA) shares surged 15 percent to $ 11.81. Actua reported a deal to sell GovDelivery to an investor group led by Vista Equity Partners for $153 million in cash.
  • GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) climbed 14.2 percent to $122.82 as the company revealed Epidiolex has achieved primary endpoint in treating Lennox-Gastaut syndrome. The positive results came from its randomized, double-blind and placebo-controlled final stage clinical study.
  • Summit Therapeutics PLC (ADR) (NASDAQ: SMMT) climbed 14.1 percent to $10.03 as the company disclosed that it has received Fast Track designation from the FDA for ezutromid in the treatment of DMD.
  • Real Goods Solar, Inc. (NASDAQ: RGSE) shares gained 14.1 percent to $2.28. Real Goods Solar shares have tumbled 91.87 percent over the past 52 weeks, while the S&P 500 index has gained 15.03 percent in the same period.
  • Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) shares rose 8.2 percent to $13.69. Jefferies reiterated Buy rating and $32 price target on Zynerba Pharmaceuticals.
  • Aldeyra Therapeutics Inc (NASDAQ: ALDX) shares climbed 7.3 percent to $8.00. H.C. Wainwright initiated coverage on Aldeyra Therapeutics with a Buy rating.
  • Diebold Inc (NYSE: DBD) gained 6.4 percent to $26.04. JP Morgan upgraded Diebold from Neutral to Overweight.
  • Columbia Pipeline Partners LP (NYSE: CPPL) gained 6.4 percent to $16.28. TransCanada Corporation (USA) (NYSE: TRP) offered to buy Columbia Pipeline Partners for $15.75 per share.
  • Exelixis, Inc. (NASDAQ: EXEL) rose 2.5 percent to $15.26 as the company disclosed that it has received a $15 million milestone payment for initiation of Phase 3 study for CS-3150.

Related Articles (ARRY + LPCN)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at